News on this topic

Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat: Pfizer beat earnings expectations and improved its outlook for the rest of the year ...
l.euronews.com/J8tF

Pfizer raises 2025 profit forecast as cost-cutting program gains traction: Pfizer said its full-year profit should benefit from cost cuts across its research and ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-raises-2025-profit-forecast-cost-cutting-program-gains-traction-2025-08-05/

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results: The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S ...
cnbc.com/2025/08/05/pfizer-pfe-q2-2025-earnings-report.html
More articles on this subject
Previous
Paid articlePaywall Pfizer lifts profit forecast despite falling sales as cost cuts take hold
businesspost.ie/markets/pfizer-lifts-profit-forecast-despite-falling-sales-as-cost-cuts-take-hold/

BioNTech partner Pfizer beats expectations – forecast raised: Pfizer exceeds expectations with Q2 sales of $14.7 billion and raises its profit forecast for 2025.
deraktionaer.de/artikel/pharma-biotech/biontech-partner-pfizer-schlaegt-die-erwartungen-prognose-rauf-20384390.html
Next
Similar to This
Previous

Belgian court sets aside Pfizer-linked seizure of Polish air traffic funds: A Belgian court has set aside an order that deprived the agency that runs Poland's ...
reuters.com/legal/litigation/belgian-court-sets-aside-pfizer-linked-seizure-polish-air-traffic-funds-2026-11-12/

Paid articlePaywall Pfizer offshoot Zoetis lines up 'potential blockbuster' pet meds for Japan: TOKYO -- The market for cancer and chronic illness treatments for pets is growing in ...
asia.nikkei.com/business/pharmaceuticals/pfizer-offshoot-zoetis-lines-up-potential-blockbuster-pet-meds-for-japan
Among ~294,000 US veterans aged 65+, Moderna's next-gen mRNA-1283 COVID-19 vaccine was associated with 36% lower risk of medically attended COVID-19 and 47% ...
jamanetwork.com/journals/jamanetworkopen/fullarticle/2856471

4 stocks to watch on Tuesday: PFE, ORCL, SHOP, and FISV: Stock futures mixed ahead of elections as Oracle, Pfizer, Shopify and Fiserv move on AI funding ...
seekingalpha.com/news/4663378-4-stocks-to-watch-on-tuesday-pfe-orcl-shop-and-fisv

20,000 Australian Students Lacked Informed COVID Vaccine Consent: Australia’s New South Wales Health Department apologised after acknowledging that more than 20 ...
greekcitytimes.com/2026/10/31/20000-australian-students-lacked-informed-covid-vaccine-consent/

Paid articlePaywall Pfizer dividend stock: Billions in write-downs after study flop - | the background!
deraktionaer.de/artikel/pharma-biotech/dividenden-aktie-pfizer-milliarden-abschreibung-nach-studienflop-die-hintergruende-20406054.html
Q1 results: L&T, HUL, Pfizer, Varun Beverages, and 70 more on July 28: Q1FY27 company results: Firms including Ambuja Cements, Suzlon Energy, Birlasoft ...
business-standard.com/companies/quarterly-results/q1-results-l-t-hul-pfizer-varun-beverages-and-70-more-on-july-28-126072800206_1.html

Polish air-traffic agency funds frozen as Pfizer enforces €1.3bn ruling for Poland's unpaid Covid vaccines
notesfrompoland.com/2026/07/11/polish-air-traffic-agency-funds-frozen-as-pfizer-enforces-e1-3bn-ruling-for-polands-unpaid-covid-vaccines/
Paid articlePaywall Former Pfizer Building Is Crumbling—Just as the Stock Has: Pfizer stock has been the worst performer among its large-cap U.S. peers over the past 10 years .
barrons.com/articles/pfizer-building-stock-54f0b3cf

Metsera deal: Pfizer completes billion-dollar takeover: Metsera shareholders have given the green light for the multi-billion dollar takeover by the ...
wiwo.de/unternehmen/industrie/metsera-deal-pfizer-schliesst-milliardenschwere-uebernahme-ab/100174549.html

Pfizer does deal with Trump on prescription drug prices: Pfizer and President Donald Trump said they had cut a deal in which the U.S.-based drugmaker agreed to ...
reuters.com/business/healthcare-pharmaceuticals/trump-announce-pfizer-drug-price-cuts-2025-09-30/

Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
cnbc.com/2025/09/12/pfizer-moderna-shares-fall-on-trump-child-covid-shot-report.html

Stocks Rally on Apple Strength: Stock Market Today
: The iPhone maker will boost its U.S. investment by $100 billion, which sent the Dow Jones stock soaring.
kiplinger.com/investing/stocks/stocks-rally-on-apple-strength-stock-market-today
Paid articlePaywall Pfizer boosts profit estimate, even as the drug giant absorbs tariffs: Pfizer’s stock rallies after drug giant cites strength in its COVID-19 drugs and Vyndaqel ...
marketwatch.com/story/pfizer-boosts-2025-profit-estimate-in-a-sign-of-confidence-b53242ae
Pfizer Q4 net profit jumps 85% to ₹331 crore; revenue rises 8.3%: Pfizer Ltd's Q4FY25 net profit surged 85% to ₹331 crore due to a one-time gain from land sale ...
business-standard.com/companies/quarterly-results/pfizer-q4-net-profit-jumps-85-to-331-crore-revenue-rises-8-3-125052000930_1.html
Paid articlePaywall Pfizer plans further $1.2bn cuts as it eyes major deals after obesity pill setback
businesspost.ie/article/pfizer-plans-further-1-2bn-cuts-as-it-eyes-major-deals-after-obesity-pill-setback/

Pfizer’s Irish staff worry about more job losses as drugmaker announces another €1.5bn in cuts
irishtimes.com/business/2025/04/29/pfizers-irish-staff-worry-about-more-job-losses-as-drugmaker-announces-another-15bn-in-cuts/
Pfizer invests $1 billion in new pharmaceutical ingredient plant in Singapore, creating 250 jobs
straitstimes.com/business/pfizer-invests-1-billion-in-new-pharmaceutical-ingredient-plant-in-singapore-creating-250-new-jobs
Key FactsPfizer Launches Advanced Manufacturing Plant in Singapore
Jul 23, 2024 · Reading time: ~45 sec.
Summary created with AI assistance · Source: straitstimes.com
Summary created with AI assistance · Source: straitstimes.com
- Pfizer officially opened a $1 billion plant in Singapore producing active pharmaceutical ingredients for cancer and antibiotic drugs.
- The new facility is an extension of Pfizer’s two-decade presence and has begun commercial manufacturing after final checks.
- It earned a Green Mark gold certification reflecting its environmental sustainability efforts aligned with net-zero goals by 2040.
- This investment enhances Singapore’s biomedical sector and generates 250 high-skilled positions within the advanced manufacturing hub.
This expanded facility not only grows our overall manufacturing footprint, but also strengthens our ability to manufacture breakthrough medicine that change patients’ lives.— Mike McDermott, Chief Global Supply Officer of Pfizer, speaking at the opening ceremony.

Pfizer: double blow before the numbers - that is expected: Two approvals in a short time.
deraktionaer.de/artikel/pharma-biotech/pfizer-doppelschlag-vor-den-zahlen-das-wird-erwartet-20356527.html
Key FactsPfizer announces two approvals before quarterly results
Apr 30, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
Summary created with AI assistance · Source: deraktionaer.de
- At the start of the week, the FDA approved Tivdak for recurrent or metastatic cervical cancer.
- Tivdak contains tisotumab vedotin, an antibody-drug conjugate Pfizer acquired through its takeover of Seagen.
- The previous week, the FDA approved Beqvez for adults with hemophilia B; the gene therapy costs $3.5 million.
- On average, analysts expect $13.9 billion revenue, $3.97 billion EBIT, and earnings of $0.31 or adjusted $0.52 per share on May 8.
Next